PROXY STATEMENT

Company

ELITE PHARMACEUTICALS INC /NV/

Filed

August 21, 2000

Period of Report

September 21, 2000

Accession Number

0001053369-00-000058

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →